Richard, last write up is for you . I liked your plan of today, for
shoring up forlorn shorts, better than yeaterday's; let me,see if
I am right: your plan is to take Vivus to new highs, 30?,35?,40?,
which will enable shorts like JohnP Carney to short it again? and ?add
to his previous short, ( unless of course he already had to cover his
shorts on the way up ), am I correct? I like this plan a lot better.
We are naw being assisted for your info by Margarita who will be snooping
the wires for us and dig up any Vivus good news! Good.
What a day! Up ~ 4 points presplit! And that without the Joslin Clinic
study which came out at 1615!!( I guess there goes the theory that
" this bad management is trying to manipulate the market and the price of
the stock " ! I agree only with the word bad: that was bad manipulation:
they should have released the study this morning at 0930! don't you think? (gg).
It is too late now to go into the significance of the Joslin study.
Perhaps Dale or Edderd can tellus ( correct me ) Re what is his
Clinic: briefly, to my best recollection, the Joslin-Lahey clinic in Boston is
the premiere ,world wide clinc on management of diabetes and it's complications;
it is a multispecialty clinic with Diabetologists. Surgeons, cardiologists,
Urologists, neurologists etc etc who handle all the Multiform complicat.
of diabetes. It's specialists hold chairs at Harvard and Boston Univ.
They have wriiten and published extesively on the subject all the way
from individual articles such as this one , to whole textbooks on
the subject ane it is were celebrities go , such as Mary Tyler Moore
i believe, who's been on Insulin for >20 yrs.
The Joslin Clinics reputation exceeds by far for medical/diabetes/impotence
matters that of fine Magazines such as Barron's or that of fine
physicians such as Padma-Nathan. So that they have the last word in
authority when a dispute should arise as to the effectiveness of Muse.
This is the 2nd nail ( the first one was the AUA's jour of Urology
editorial on impotence I mentioned earlier ) to the Barron/PadmaNathan?Alpert
article on impotence, and the coffin is now firmly shut.
The stock, Vivus, will take it from here, tomorrow.
At this time my tendency is to hold on tight to it , for the ride, and
not to trade it.
TA. |
